Dolby Laboratories, Inc. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dolby Laboratories, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Dolby Laboratories, Inc. for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | M | 45.50 | 21,850 | 994,175 | 0 | |
Dec 23 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 94.00 | 21,850 | 2,053,900 | 32,376 | 54.2 K to 32.4 K (-40.29 %) |
Dec 23 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Buy | M | 45.50 | 21,850 | 994,175 | 54,226 | 32.4 K to 54.2 K (+67.49 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 92.07 | 5,168 | 475,830 | 38,252 | 43.4 K to 38.3 K (-11.90 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Payment of Exercise | F | 91.03 | 5,082 | 462,614 | 106,414 | 111.5 K to 106.4 K (-4.56 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 91.96 | 1,638 | 150,629 | 51,673 | 53.3 K to 51.7 K (-3.07 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Payment of Exercise | F | 91.03 | 1,612 | 146,740 | 53,311 | 54.9 K to 53.3 K (-2.94 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Payment of Exercise | F | 91.03 | 1,116 | 101,589 | 35,262 | 36.4 K to 35.3 K (-3.07 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 91.03 | 217 | 19,754 | 12,460 | 12.7 K to 12.5 K (-1.71 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Payment of Exercise | F | 91.03 | 1,116 | 101,589 | 57,846 | 59 K to 57.8 K (-1.89 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Payment of Exercise | F | 91.03 | 1,612 | 146,740 | 105,598 | 107.2 K to 105.6 K (-1.50 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 92.30 | 1,575 | 145,373 | 32,376 | 34 K to 32.4 K (-4.64 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 91.65 | 1,575 | 144,349 | 33,951 | 35.5 K to 34 K (-4.43 %) |
Dec 21 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Payment of Exercise | F | 91.03 | 1,550 | 141,097 | 35,526 | 37.1 K to 35.5 K (-4.18 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | A | 92.08 | 91,597 | 8,434,252 | 91,597 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | A | 0.00 | 21,394 | 0 | 21,394 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Payment of Exercise | F | 92.08 | 5,268 | 485,077 | 116,664 | 121.9 K to 116.7 K (-4.32 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 91.61 | 1,771 | 162,239 | 32,895 | 34.7 K to 32.9 K (-5.11 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 90.60 | 9,768 | 885,024 | 34,666 | 44.4 K to 34.7 K (-21.98 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Grant | A | 0.00 | 42,789 | 0 | 127,289 | 84.5 K to 127.3 K (+50.64 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Payment of Exercise | F | 90.86 | 11,349 | 1,031,170 | 84,500 | 95.8 K to 84.5 K (-11.84 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | A | 92.08 | 30,553 | 2,813,320 | 30,553 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | A | 0.00 | 7,136 | 0 | 7,136 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 91.66 | 337 | 30,888 | 54,923 | 55.3 K to 54.9 K (-0.61 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 90.62 | 3,065 | 277,748 | 55,260 | 58.3 K to 55.3 K (-5.26 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Payment of Exercise | F | 92.08 | 1,637 | 150,735 | 58,325 | 60 K to 58.3 K (-2.73 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Grant | A | 0.00 | 14,272 | 0 | 59,962 | 45.7 K to 60 K (+31.24 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Payment of Exercise | F | 90.86 | 3,348 | 304,199 | 45,690 | 49 K to 45.7 K (-6.83 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 92.08 | 27,253 | 2,509,456 | 27,253 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | A | 0.00 | 6,365 | 0 | 6,365 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Payment of Exercise | F | 92.08 | 1,153 | 106,168 | 36,378 | 37.5 K to 36.4 K (-3.07 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Grant | A | 0.00 | 12,731 | 0 | 37,531 | 24.8 K to 37.5 K (+51.33 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 92.08 | 195 | 17,956 | 12,677 | 12.9 K to 12.7 K (-1.51 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Grant | A | 0.00 | 4,500 | 0 | 12,872 | 8.4 K to 12.9 K (+53.75 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 90.86 | 444 | 40,342 | 8,372 | 8.8 K to 8.4 K (-5.04 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Option Exercise | M | 45.50 | 834 | 37,947 | 0 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Sell | S | 92.00 | 834 | 76,728 | 58,962 | 59.8 K to 59 K (-1.39 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Buy | M | 45.50 | 834 | 37,947 | 59,796 | 59 K to 59.8 K (+1.41 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Forshay Steven E | SVP, Advanced Techn ... | Payment of Exercise | F | 90.86 | 2,356 | 214,066 | 58,962 | 61.3 K to 59 K (-3.84 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | A | 92.08 | 30,553 | 2,813,320 | 30,553 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 7,136 | 0 | 7,136 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Payment of Exercise | F | 92.08 | 1,637 | 150,735 | 107,210 | 108.8 K to 107.2 K (-1.50 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Grant | A | 0.00 | 14,272 | 0 | 108,847 | 94.6 K to 108.8 K (+15.09 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Payment of Exercise | F | 90.86 | 3,472 | 315,466 | 94,575 | 98 K to 94.6 K (-3.54 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | M | 45.50 | 959 | 43,635 | 0 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | A | 92.08 | 28,903 | 2,661,388 | 28,903 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Option Exercise | A | 0.00 | 6,750 | 0 | 6,750 | |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 91.31 | 526 | 48,031 | 37,076 | 37.6 K to 37.1 K (-1.40 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 91.00 | 433 | 39,403 | 37,602 | 38 K to 37.6 K (-1.14 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Buy | M | 45.50 | 959 | 43,635 | 38,035 | 37.1 K to 38 K (+2.59 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Payment of Exercise | F | 92.08 | 1,550 | 142,724 | 37,076 | 38.6 K to 37.1 K (-4.01 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 91.92 | 702 | 64,530 | 38,626 | 39.3 K to 38.6 K (-1.78 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Sell | S | 90.90 | 2,385 | 216,808 | 39,328 | 41.7 K to 39.3 K (-5.72 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Grant | A | 0.00 | 13,501 | 0 | 41,713 | 28.2 K to 41.7 K (+47.86 %) |
Dec 17 2020 | DLB | Dolby Laboratories ... | Baker Giles | SVP, Consumer Enter ... | Payment of Exercise | F | 90.86 | 3,038 | 276,033 | 28,212 | 31.3 K to 28.2 K (-9.72 %) |